Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Hypha Labs, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
Mi | Hypha Labs Inc. and Emerging Markets Consulting LLC: Emerging Markets Report: Breakthroughs & Bureaucracy | 1 | GlobeNewswire (USA) | ||
HYPHA LABS Aktie jetzt für 0€ handeln | |||||
30.01. | Hypha Labs, Inc.: Hypha Laboratories Reports Significant Breakthrough for MicroPearls Yields | 223 | ACCESS Newswire | In-Home Consumer Harvests Increase Exponentially After Research Discovery at Hypha Laboratories LAS VEGAS, NEVADA / ACCESS Newswire / January 30, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional... ► Artikel lesen | |
27.01. | Hypha Labs, Inc.: Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms | 185 | ACCESS Newswire | Legislative Changes Usher Acceptance, Broaden Market Opportunity for Early Adopters LAS VEGAS, NV / ACCESS Newswire / January 27, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom... ► Artikel lesen | |
24.01. | Hypha Labs, Inc. - 8-K, Current Report | - | SEC Filings | ||
16.01. | Hypha Labs, Inc. - 8-K, Current Report | - | SEC Filings | ||
13.01. | Hypha Labs, Inc. - 10-K, Annual Report | - | SEC Filings | ||
31.12.24 | Hypha Labs, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
16.12.24 | Hypha Labs, Inc. - 8-K, Current Report | - | SEC Filings | ||
18.11.24 | Hypha Labs, Inc.: Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls Prototypes | 253 | ACCESS Newswire | Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom... ► Artikel lesen | |
17.10.24 | Hypha Labs Inc. and Emerging Markets Consulting LLC: Emerging Markets Report: A Mushroom Monster in the Making | 1 | GlobeNewswire (USA) | ||
15.10.24 | Hypha Labs, Inc.: Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown | 257 | ACCESS Newswire | Board Will Add to Company's Intellectual Capital and Diversity of ExperienceLAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and... ► Artikel lesen | |
07.10.24 | Hypha Labs, Inc.: Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production | 266 | ACCESS Newswire | Company Intends to Bring First Functional Mushroom Producer to RetailLAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator... ► Artikel lesen | |
30.09.24 | Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production | 234 | ACCESS Newswire | First Generation 'MicroPearls Pro'and "MicroPearls ProX" Will Support Largest Mushroom Ingredient CategoriesLAS VEGAS, NV / ACCESSWIRE / September 30, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer... ► Artikel lesen | |
26.09.24 | Hypha Labs, Inc.: Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services | 242 | ACCESS Newswire | LAS VEGAS, NV / ACCESSWIRE / September 26, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has retained Emerging Markets Consulting... ► Artikel lesen | |
23.09.24 | Hypha Labs, Inc. Releases Investor Presentation | 265 | ACCESS Newswire | Dynamic Deck Outlines Company's Plan to Empower Home and Commercial Production of Functional Mushroom Ingredients LAS VEGAS, NV / ACCESSWIRE / September 23, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer... ► Artikel lesen | |
16.09.24 | Hypha Labs, Inc. Uplists to the OTCQB | 337 | ACCESS Newswire | OTCQB Listing Brings Transparency, Prestige and Beneficial Exposure LAS VEGAS, NV / ACCESSWIRE / September 16, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased... ► Artikel lesen | |
20.08.24 | Hypha Labs, Inc.: Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press | 307 | ACCESS Newswire | LAS VEGAS, NV / ACCESSWIRE / August 20, 2024 / Hypha Labs, Inc. (OTC PINK:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company's proprietary bioreactor which allows... ► Artikel lesen | |
13.08.24 | Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. | 539 | ACCESS Newswire | LAS VEGAS, NV / ACCESSWIRE / August 13, 2024 / Hypha Labs, Inc. formerly (OTC PINK:DIGP), has been approved to commence trading as Hypha Labs, Inc. (OTC PINK:FUNI) on August 13, 2024. Hypha Labs has... ► Artikel lesen | |
31.07.24 | Hypha Labs, Inc.: Hypha Labs' Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press | 369 | ACCESS Newswire | LAS VEGAS, NV / ACCESSWIRE / July 31, 2024 / Hypha Labs, Inc. (OTC PINK:DIGP), a pioneer in functional mushroom sciences, is pleased to announce that the Company's proprietary bioreactor which allows... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TEMPUS AI | 89,47 | +6,83 % | Why Tempus AI, Inc. (TEM) Soared Last Week | ||
RECURSION PHARMACEUTICALS | 10,555 | +24,18 % | Why Recursion Pharmaceuticals Inc. (RXRX) Soared on Friday? | ||
QIAGEN | 38,265 | +0,70 % | Kurznachrichten zu Siltronic, Qiagen und Freenet | Mit unseren Kurznachrichten bieten wir kompakte Updates zu einer Handvoll ausgewählter Aktien für den perfekten Überblick - prägnant, informativ und auf den Punkt. Trotz der etwas besser als erwarteten... ► Artikel lesen | |
SPRINGWORKS THERAPEUTICS | 57,34 | -2,13 % | Milliarden-Deal geplant: Merck greift nach dem Krebsspezialisten Springworks Therapeutics | © Foto: Arne Dedert/dpaDer Darmstädter Pharmakonzern Merck steht kurz vor einer Milliardenübernahme in den USA. Das DAX-Unternehmen bestätigte fortgeschrittene Gespräche mit dem Krebsspezialisten Springworks.Springworks... ► Artikel lesen | |
EVOTEC | 8,765 | +0,46 % | Evotec Aktie: Ein zäher Weg voraus! | Die Evotec-Aktie verzeichnet am heutigen Handelstag weitere Einbußen und setzt damit ihren jüngsten Abwärtstrend fort. Im XETRA-Handel sackte der Kurs um 2,5 Prozent auf 8,56 Euro ab, nachdem das Papier... ► Artikel lesen | |
VERA THERAPEUTICS | 27,470 | -19,63 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on February 8, 2025, the Compensation Committee granted inducement awards consisting... ► Artikel lesen | |
ALLOGENE THERAPEUTICS | 1,995 | +41,49 % | Allogene's phase 1 lymphoma data show CAR-T could 'leapfrog' competition: analysts | ||
BEAM THERAPEUTICS | 32,400 | +13,25 % | Beam Therapeutics (NASDAQ:BEAM) Shares Up 17.9% - Here's Why | ||
SUMMIT THERAPEUTICS | 21,365 | -2,09 % | Summit Therapeutics Aktie: Verunsicherung steigt! | Summit Therapeutics, ein biopharmazeutisches Unternehmen, verzeichnet einen bemerkenswerten Aufschwung an der Börse. Die Aktie schloss am 9. November 2024 bei 21,41 USD, was einem Anstieg von 1,47%... ► Artikel lesen | |
ABSCI | 5,795 | +15,90 % | Absci Corporation: Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery | VANCOUVER, Wash., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration with AMD to deploy... ► Artikel lesen | |
AVIDITY BIOSCIENCES | 32,310 | -2,15 % | Avidity Biosciences, Inc.: Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025 | Accelerated approval path confirmed for del-zota; Biologics License Application (BLA) submission planned for year end 2025
On track to complete enrollment in del-desiran... ► Artikel lesen | |
BIONTECH | 113,80 | -0,52 % | ÜBERNAHME?! Renk, BioNTech und Biotech-Highflyer Vidac Pharma Aktie | Steht Renk vor der Übernahme? Gut möglich. Der für seine Getriebe für den Leopard-Panzer bekannte Konzern hat jedenfalls einen neuen Großaktionär. Und dabei handelt es sich ausgerechnet um KNDS - Hersteller... ► Artikel lesen | |
EDGEWISE THERAPEUTICS | 25,480 | -2,08 % | JPMorgan lifts Edgewise Therapeutics target to $45 | ||
PRAXIS PRECISION MEDICINES | 90,88 | +4,87 % | Praxis Precision Medicines (NASDAQ:PRAX) Sets New 12-Month High - Should You Buy? | ||
JANUX THERAPEUTICS | 36,480 | -1,94 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen |